INTERNATIONAL PATENT: JIANGSU INSTITUTE OF NUCLEAR MEDICINE, 江苏省原子医学研究所 FILES APPLICATION FOR "POLYPEPTIDE TARGETING FGL1 AND USE THEREOF"

GENEVA, Sept. 28 -- JIANGSU INSTITUTE OF NUCLEAR MEDICINE (No. 20 Qianrong Road, Binhu DistrictWuxi, Jiangsu 214000), 江苏省原子医学研究所 (中国江苏省无锡市滨湖区钱荣路20号) filed a patent application (PCT/CN2025/081776) for "POLYPEPTIDE TARGETING FGL1 AND USE THEREOF" on Mar 11, 2025. With publication no. WO/2025/195225, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XU, Y...